AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+2.75%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.17B
AUM Growth
+$2.17B
Cap. Flow
+$155M
Cap. Flow %
7.14%
Top 10 Hldgs %
58.3%
Holding
120
New
20
Increased
21
Reduced
32
Closed
19

Sector Composition

1 Healthcare 72.1%
2 Consumer Discretionary 17.9%
3 Technology 5.46%
4 Communication Services 2.13%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GS icon
101
Goldman Sachs
GS
$226B
0
IFRX icon
102
InflaRx
IFRX
$108M
-825,000 Closed -$31.2M
INCY icon
103
Incyte
INCY
$16.5B
0
LRMR icon
104
Larimar Therapeutics
LRMR
$310M
-700,000 Closed -$1.92M
MLCO icon
105
Melco Resorts & Entertainment
MLCO
$3.88B
0
NBIX icon
106
Neurocrine Biosciences
NBIX
$13.8B
0
QCOM icon
107
Qualcomm
QCOM
$173B
0
TIGR
108
UP Fintech Holding
TIGR
$2.21B
-100,000 Closed -$1.29M
VICI icon
109
VICI Properties
VICI
$36B
-400,000 Closed -$8.75M
VRDN icon
110
Viridian Therapeutics
VRDN
$1.5B
-500,000 Closed -$1.4M
WVE icon
111
Wave Life Sciences
WVE
$1.53B
-250,000 Closed -$9.71M
WHWK
112
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
-1,558,400 Closed -$1.4M
CMRX
113
DELISTED
Chimerix, Inc.
CMRX
-500,000 Closed -$1.05M
SWAV
114
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-150,000 Closed -$5.02M
CBAY
115
DELISTED
Cymabay Therapeutics
CBAY
-600,000 Closed -$7.97M
ICPT
116
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-50,000 Closed -$5.59M
TRIL
117
DELISTED
Trillium Therapeutics Inc.
TRIL
-150,000 Closed -$99K
NVLN
118
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
-256,400 Closed -$315K
ARRY
119
DELISTED
Array Biopharma Inc
ARRY
-2,000,000 Closed -$48.8M
ZGNX
120
DELISTED
Zogenix, Inc.
ZGNX
-200,000 Closed -$11M